Medicare To Cover "Routine Care Costs" Of Private And Public Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration intends to allow Medicare coverage "of routine care costs" for all device trials conducted under IDEs, provided they fall within statutory benefits, according to the agency.
You may also be interested in...
Unique Missions Of FDA, CMS Underscored In Presentations To HHS Panel
Ongoing attempts to coordinate FDA and CMS reviews will preserve approval, coverage, coding and payment as distinct processes, agency representatives concurred at the HHS Secretary's Advisory Committee on Regulatory Reform regional hearing June 10
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”